Tectonic Therapeutic, Inc.

US$20.64As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TECXHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR 10.05%
Div yield —
ROE (35.46%)
Biotechnology
Beta (5Y) 0.51
PE TTM —
TSR TTM 13.10%
Mkt cap US$403.5M
ROIC (24.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$26
26.85%
(66.51%)
Hold 0|6|7|11|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.24
0.26
0.29
0.29
15.85%
19.00%
17.03%
19.86%
Revenue$M
18.05
19.03
19.68
19.31
6.36%
15.18%
18.92%
10.24%
Peers (US$403.5M)
Cap (US$)
PE
404.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.406
0.115
0.118
EBIT/Intx
0.390
0.352
0.345
Own earn%
36.04
19.03
13.52
Sh yield%
38.14
46.98
46.96
Owners
Insiders/Inst%
10.85
32.37
Short interest%
2.87
SBC / revenue%
4.03
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
23–28
$1 testx
—
Incr. ROIC%
8